A61K 31/421
1,3-oxazoles
Official title: 1,3-Oxazoles, e.g. pemoline, trimethadione
A61K31/421 (1,3-oxazoles) appears on 629 US grants and 1,141 published applications in this corpus.
Search patents in A61K- Granted patents
- 629
- Published applications
- 1,141
- Assignees
- 494
- Inventors
- 2,474
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 12 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 1 |
| 2002 | 8 | 12 |
| 2003 | 13 | 63 |
| 2004 | 28 | 80 |
| 2005 | 20 | 47 |
| 2006 | 48 | 57 |
| 2007 | 12 | 41 |
| 2008 | 21 | 38 |
| 2009 | 15 | 42 |
| 2010 | 22 | 34 |
| 2011 | 16 | 35 |
| 2012 | 24 | 42 |
| 2013 | 25 | 44 |
| 2014 | 27 | 56 |
| 2015 | 33 | 50 |
| 2016 | 33 | 44 |
| 2017 | 43 | 58 |
| 2018 | 30 | 58 |
| 2019 | 32 | 56 |
| 2020 | 34 | 41 |
| 2021 | 26 | 59 |
| 2022 | 20 | 35 |
| 2023 | 22 | 37 |
| 2024 | 20 | 43 |
| 2025 | 16 | 35 |
| 2026 | 9 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- TEAD inhibitors29 Sep 2026US 12,747,207 B2Orion Corporation
- Method for preventing and/or treating liver fibrosis by using 6-methoxybenzoxazolinone and Coix lachryma-jobi L. extract comprising 6-methoxybenzoxazolinone15 Sep 2026US 12,734,157 B2Taichung District Agricultural Research and Extension Station, Ministry of Agriculture
- Compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient28 Jul 2026US 12,691,101 B2Yonsei University, University—Industry Foundation (Uif)
- Method for the production of commercial nanoparticle and microparticle powders7 Jul 2026US 12,673,027 B2iCeutica Pty Ltd.
- TREM2 agonists for the stimulation of microglia and methods of identification16 Jun 2026US 12,653,803 B2The Translational Genomics Research Institute
- Trem2 agonists for the stimulation of microglia and methods of identification8 Oct 2026US 2026/0306439 A1The Translational Genomics Research Institute
- Tomm6-interacting extracts and compounds for use in the treatment and prophylaxis of nervous system diseases, atherosclerosis, hepatitis b infection and human papilloma virus (hpv) infection8 Oct 2026US 2026/0306473 A1
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Compounds for treating rett syndrome and other disorders24 Sep 2026US 2026/0283990 A1Unravel Biosciences, Inc.
- Wound treatment composition17 Sep 2026US 2026/0272888 A1Otsuka Pharmaceutical Co., Ltd.
Most cited
By later US patents
- Methods and devices for providing prolonged drug therapy267US 6,919,373 B1Alza Corporation · 2005
- Delivery of erectile dysfunction drugs through an inhalation route120US 6,803,031 B2Alexza Molecular Delivery Corporation · 2004
- Methods and devices for providing prolonged drug therapy118US 6,930,129 B2Alza Corporation · 2005
- Delivery of opioids through an inhalation route113US 7,169,378 B2Alexza Pharmaceuticals, Inc. · 2007
- Delivery of opioids through an inhalation route107US 6,776,978 B2Alexza Molecular Delivery Corporation · 2004